Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00872_DB06697> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00872_DB06697 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00872_DB06697 label "DDI between Conivaptan and Artemether - Conivaptan, a strong CYP3A inhibitor, may increase the toxicity of artemether by inhibiting its metabolism. Consider alternate therapy or allow at least 7 days to elapse between conivaptan and artemether therapy. [drugbank_resource:DB00872_DB06697]" assertion.
- drugbank_resource:DB00872_DB06697 identifier "drugbank_resource:DB00872_DB06697" assertion.
- drugbank_resource:DB00872_DB06697 title "DDI between Conivaptan and Artemether - Conivaptan, a strong CYP3A inhibitor, may increase the toxicity of artemether by inhibiting its metabolism. Consider alternate therapy or allow at least 7 days to elapse between conivaptan and artemether therapy." assertion.